Hormone therapy in women in their fifties has shown a surprising 30% reduction in mortality from various causes. While some risks, like increased blood clotting, were noted, the overall outcomes were less harmful than anticipated, with a slight decrease in breast cancer incidence and significant reductions in colon cancer and bone fractures. The timeline of breast cancer development suggests that hormone therapy does not directly cause the disease, as it typically initiates years before detection.